These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1129657)

  • 21. [Blood platelet qualitative defects].
    Dioguardi N
    Minerva Med; 1974 Nov; 65(84):4351-61. PubMed ID: 4215988
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long remission in acute myeloblastic leukemia during Vaquez' polycythemia. Acute transformation of a myeloproliferative syndrome or successive neoplasms?].
    Dhermy D; Bernard JF; Renoux M; Boivin P
    Sem Hop; 1978 Sep 18-25; 54(25-28):814-7. PubMed ID: 214860
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chronic myeloid leukemia with progression to polycythemia vera].
    Campo MC; Fortún A; Travieso J
    Sangre (Barc); 1992 Jun; 37(3):207-8. PubMed ID: 1440100
    [No Abstract]   [Full Text] [Related]  

  • 24. Aetiology of splenomegaly.
    Sainani GS; Khurana BK
    J Assoc Physicians India; 1974 Dec; 22(12):893-9. PubMed ID: 4455677
    [No Abstract]   [Full Text] [Related]  

  • 25. Retinopathy secondary to anemia from myeloid metaplasia in polycythemia vera.
    Blood AM; Lowenthal EA; Nowakowski RW
    J Am Optom Assoc; 1997 Nov; 68(11):734-8. PubMed ID: 9409109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypersplenism in liver cirrhosis].
    Tsuji H; Fujishima M
    Nihon Rinsho; 1994 Jan; 52(1):85-90. PubMed ID: 8114316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunitary disorders during myeloid splenomegaly with myelofibrosis].
    Boivin P; Hakim J; Kahn A; Bernard JF
    Nouv Presse Med; 1972 Apr; 1(14):960. PubMed ID: 5019303
    [No Abstract]   [Full Text] [Related]  

  • 28. Leukoerythroblastosis. Diagnostic and prognostic significance.
    Weick JK; Hagedorn AB; Linman JW
    Mayo Clin Proc; 1974 Feb; 49(2):110-3. PubMed ID: 4544259
    [No Abstract]   [Full Text] [Related]  

  • 29. The neurologic manifestations of lymphoma, leukemia and myeloma (including polycythemia vera and macroglobulinemia).
    AITA JA
    Nebr State Med J; 1962 Mar; 47():142-8. PubMed ID: 13859830
    [No Abstract]   [Full Text] [Related]  

  • 30. [Amyloidosis and polycythemia vera (author's transl)].
    Laudet J; Baumelou E; Chaignon M; Chapman A
    Sem Hop; 1981 Dec 8-15; 57(45-46):1951-4. PubMed ID: 6275536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 'spent' phase of polycythaemia vera: hypersplenism in the absence of myelofibrosis.
    Najean Y; Arrago JP; Rain JD; Dresch C
    Br J Haematol; 1984 Jan; 56(1):163-70. PubMed ID: 6584168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Splenectomy for agnogenic myeloid metaplasia.
    Coon WW; Liepman MK
    Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Splenectomy in massive splenomegaly due to hypersplenism].
    González Rodríguez FJ; Puñal JA; Beiras Torrado A; Potel Lesquereaux J
    Cir Esp; 2008 Feb; 83(2):95-6. PubMed ID: 18261418
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the haemodilution anaemia of splenomegaly.
    Blendis LM; Ramboer C; Williams R
    Eur J Clin Invest; 1970 Mar; 1(1):54-64. PubMed ID: 5470478
    [No Abstract]   [Full Text] [Related]  

  • 35. [Reno-ureteral dislocation produced by splenic enhr gement].
    SELLI M; PEDETTA GP; SICARI A
    Urol Int; 1962; 14():257-91. PubMed ID: 13987807
    [No Abstract]   [Full Text] [Related]  

  • 36. SPLENECTOMY: INDICATIONS AND RESULTS IN HEMATOLOGIC DISORDERS.
    SANDUSKY WR; LEAVELL BS; BENJAMIN BI
    Ann Surg; 1964 May; 159(5):695-710. PubMed ID: 14153806
    [No Abstract]   [Full Text] [Related]  

  • 37. Polycythemia vera: its course and treatment; relation to myeloid metaplasia and leukemia.
    WASSERMAN LR
    Bull N Y Acad Med; 1954 May; 30(5):343-75. PubMed ID: 13150002
    [No Abstract]   [Full Text] [Related]  

  • 38. Dyssplenism secondary to chronic leukemia or malignant lymphoma.
    REINHARD EH; LOEB V
    J Am Med Assoc; 1955 Jun; 158(8):629-34. PubMed ID: 14381227
    [No Abstract]   [Full Text] [Related]  

  • 39. Folate deficiency in the myeloproliferative disorders.
    Chanarin I
    Am J Clin Nutr; 1970 Jun; 23(6):855-60. PubMed ID: 5431049
    [No Abstract]   [Full Text] [Related]  

  • 40. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome.
    Ward HP; Block MH
    Medicine (Baltimore); 1971 Sep; 50(5):357-420. PubMed ID: 4940717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.